These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1711915

  • 1. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
    Seiffert D, Mimuro J, Schleef RR, Loskutoff DJ.
    Cell Differ Dev; 1990 Dec 02; 32(3):287-92. PubMed ID: 1711915
    [Abstract] [Full Text] [Related]

  • 2. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
    Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G.
    J Biol Chem; 1990 Oct 25; 265(30):18490-8. PubMed ID: 1698787
    [Abstract] [Full Text] [Related]

  • 3. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ, Gebbink RK, Preissner KT, Keijer J, Esmon NL, Mertens K, Pannekoek H.
    J Cell Biol; 1991 Dec 25; 115(6):1773-81. PubMed ID: 1721912
    [Abstract] [Full Text] [Related]

  • 4. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
    Owensby DA, Morton PA, Wun TC, Schwartz AL.
    J Biol Chem; 1991 Mar 05; 266(7):4334-40. PubMed ID: 1705551
    [Abstract] [Full Text] [Related]

  • 5. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C, Stüber W, Ehrlich HJ, Pannekoek H, Preissner KT.
    J Biol Chem; 1992 Jun 15; 267(17):12098-105. PubMed ID: 1376317
    [Abstract] [Full Text] [Related]

  • 6. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 7. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.
    Kirchheimer JC, Binder BR, Remold HG.
    J Immunol; 1990 Sep 01; 145(5):1518-22. PubMed ID: 1696600
    [Abstract] [Full Text] [Related]

  • 8. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH.
    J Cell Biol; 1991 Oct 01; 115(1):191-9. PubMed ID: 1918136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.
    Niedbala MJ, Picarella MS.
    Blood; 1992 Feb 01; 79(3):678-87. PubMed ID: 1732009
    [Abstract] [Full Text] [Related]

  • 13. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J, Ehrlich HJ, Linders M, Preissner KT, Pannekoek H.
    J Biol Chem; 1991 Jun 05; 266(16):10700-7. PubMed ID: 1709939
    [Abstract] [Full Text] [Related]

  • 14. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 05; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ.
    J Cell Biol; 1990 Jan 05; 110(1):155-63. PubMed ID: 2104856
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment.
    Knudsen BS, Nachman RL.
    J Biol Chem; 1988 Jul 05; 263(19):9476-81. PubMed ID: 2967824
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Collagen modulates gene activation of plasminogen activator system molecules.
    Jones JM, Cohen RL, Chambers DA.
    Exp Cell Res; 2002 Nov 01; 280(2):244-54. PubMed ID: 12413890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.